Fundraising FoxBlueYard Capital — 2025 Investments
6 investments dated 2025 · listed companies and verified rows first · show all
Datagon builds industrial AI solutions that operate in production environments.
Advanced ManufacturingAI & Machine Learning
Co-investorsCapmont TechnologyCDTM Venture FundLightspeed Venture PartnersTechFounders
Aerska develops RNA interference (RNAi) medicines designed for targeted delivery across the blood-brain barrier to treat, delay, and prevent central nervous system and neurological diseases.
BiotechDeep TechHealthtechMedical Devices
Stuart Milstein(Chief Platform Officer, Co-founder)inJack O’Meara(Chief Executive Officer, Co-founder)inDave Hardwicke(Director, Head of Business Development, Co-founder)
Co-investorsage1BackedEntrepreneur FirstGlobal Health Investment CorporationIaso VenturesLingotto+6 more
Corintis designs, builds, tests, and mass-produces microfluidic cold plates and co-packaged liquid cooling solutions for high-power chips such as GPUs in data centers and HPC applications.
Deep TechHardwareSemiconductors
Co-investorsAcequia Capital (AceCap)Celesta Capital
Manex AI builds an autonomous enterprise AI platform and manufacturing software suites that unify production data so AI agents and workflows can act on it for quality, execution, and shopfloor operations.
Advanced ManufacturingAI & Machine LearningEnterprise SoftwareMunich, DE
Dr. Andreas Schoch(Founder)inNathan Gruber(Founder)in
Co-investorsCapmontLightspeed Venture PartnersCapmont TechnologyCDTM Venture Fund
Privy provides infrastructure for building crypto wallets and moving digital assets, enabling developers to integrate wallet functionality, stablecoin transfers, and automated payment systems into their applications.
Crypto & Web3Developer ToolsFintechBoston, US
Asta L.(Founder)inBen Jabbawy(Executive Officer, Director)Asta Li(Founder)Henri Stern(Founder)in
BoardSamuel Clemens(Director)
Co-investorsArchetypeBitDAOBoxGroupCoinbase VenturesCypress Growth CapitalElectric Capital+12 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.